Medpace Holdings, Inc.
MEDP
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and develā¦ read more
Healthcare
Diagnostics & Research
9 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$419.17
Price-1.08%
-$4.59
1Y
Price
Market Cap
$11.971b
Large
Price/Earnings 3y Avg5y Avg
26.4x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+21.0%
EBITDA Margin+17.5%
Net Profit Margin+20.5%
Free Cash Flow Margin+21.0%
EBITDA Margin+17.5%
Net Profit Margin+20.5%
Free Cash Flow MarginRevenue
$2.678b
+5.9%
1y CAGR+12.6%
3y CAGR+16.7%
5y CAGREarnings
$460.398m
+2.1%
1y CAGR+18.9%
3y CAGR+18.0%
5y CAGREPS
$15.92
+4.2%
1y CAGR+22.5%
3y CAGR+22.4%
5y CAGRBook Value
$598.314m
$2.130b
Assets$1.531b
Liabilities$146.094m
DebtDebt to Assets
6.9%
0.2x
Debt to EBITDAFree Cash Flow
$737.819m
+8.2%
1y CAGR+23.9%
3y CAGR+21.2%
5y CAGRNo items found.
Press Releases
Statements and updates from the company